Blood pressure medicine recalled

Blood pressure medicine recalled

"Aurobindo Pharma USA, Inc.is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product".

Losartan potassium tablets USP are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and nephropathy in Type 2 diabetic patients.

This recall includes 30-, 90- and 1,000-count bottles of 100-milligram tablets; 30-, 90- and 1,000-count bottles of 50-milligram tablets; and 90-count bottles of 25-milligram tablets.

Valsartan is generally used in treating heart failure, blood pressure as well as to reduce the risk of death after going through a heart attack.

The impurity N-Nitrosodiethylamine (NDEA) was detected in quantities above the acceptable limit in certain tablets containing valsartan, the FDA said. BO31C016 and 4DK3C005 of Losartan Potassium USP tablets.

According to reliable reports, NDEA is a synthetic oil that is used as a stabilizer and antioxidant in plastics and also as a lubricant additive. Some tablets may contain a possible cancer-causing substance. Ltd., and by Hetero Labs Ltd.

Erdogan welcomes Pakistan’s decision to declare Gulen-backed organisation a terror outfit
The Prime Minister said our main concern is to take people out of poverty and this will be done by promoting wealth creation. He said both sides also discussed their efforts regarding the attack helicopter and wanted to explore further collaboration.

"Patients taking the recalled valsartan-containing medicines should consult their doctor or pharmacist and continue taking their medicine until they have a replacement product", Dr. Suzanne Steinbaum of Mount Sinai in NY told CNN after a similar recall past year.

The FDA continues to test the ingredient for cancer-causing chemicals.

Instructions for returning recalled products are given in the recall letter. The recalls have been expanded several times since the initial recall over the summer.

It's unclear exactly what the cancer risk is if you take the contaminated pills; the FDA believes that the risk is low.

On 31st of December, Aurobindo Pharma USA did not receive any kind of reports related to the adverse reactions which are associated with the recent recall based on a recent commentary.

Related Articles